Asia is a continent of superlatives. It’s home to the two most populous countries, three of the biggest economies and the nation with the oldest population.

Underneath these statistics lies a fundamental truth: Asia isn’t one homogenous market. It’s a patchwork of profoundly different countries, each with its own unique cultures, languages, regulations and conditions that provide diverse environments where healthcare companies, innovators and providers can thrive.

The investment picture is positive. Asia’s healthcare market has held steady in spite of volatility seen in other areas of the private market landscape at points, buoyed by growing demand for enhanced healthcare solutions and unmet medical needs across the continent.

Large and Growing Addressable Asia Pacific Healthcare Market

Asia Pacific Healthcare Market Size

Source: EQT

Deal values have risen at a compound annual growth rate (CAGR) of roughly 21 percent between 2016 and 2024, according to data compiled by Dealogic and Bain, and the Asia Pacific (APAC) healthcare market is expected to grow from $2.3tn in 2023 to $4.3tn in 2030.

That growth stems both from core products and services, such as generic drug manufacturing and hospital management, as well as new technologies. Innovation in healthcare is inherently slower than in other industries because of the need for rigorous testing and strict regulation to safeguard human life. However, across Asia, the results speak for themselves: lower costs, better patient experiences and improved outcomes.

Understanding what’s driving growth in individual countries is essential to identify future opportunities in Asian healthcare. This report looks at four markets shaping the future of the continent: China, India, Japan and South Korea.

Download the full report here.